BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20962241)

  • 1. Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density.
    Stelzel C; Basten U; Montag C; Reuter M; Fiebach CJ
    J Neurosci; 2010 Oct; 30(42):14205-12. PubMed ID: 20962241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior cognitive goal maintenance in carriers of genetic markers linked to reduced striatal D2 receptor density (C957T and DRD2/ANKK1-TaqIA).
    Persson J; Stenfors C
    PLoS One; 2018; 13(8):e0201837. PubMed ID: 30125286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance.
    Bertolino A; Taurisano P; Pisciotta NM; Blasi G; Fazio L; Romano R; Gelao B; Lo Bianco L; Lozupone M; Di Giorgio A; Caforio G; Sambataro F; Niccoli-Asabella A; Papp A; Ursini G; Sinibaldi L; Popolizio T; Sadee W; Rubini G
    PLoS One; 2010 Feb; 5(2):e9348. PubMed ID: 20179754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the molecular genetics of flexibility: the case of task-switching, inhibitory control and genetic variants.
    Markett S; Montag C; Walter NT; Plieger T; Reuter M
    Cogn Affect Behav Neurosci; 2011 Dec; 11(4):644-51. PubMed ID: 21994116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT and DRD2/ANKK-1 gene-gene interaction account for resetting of gamma neural oscillations to auditory stimulus-driven attention.
    Garcia-Garcia M; Via M; Zarnowiec K; SanMiguel I; Escera C; Clemente IC
    PLoS One; 2017; 12(2):e0172362. PubMed ID: 28222164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of a DRD2 polymorphism on updating of long-term memory representations and caudate BOLD activity: magnification in aging.
    Persson J; Rieckmann A; Kalpouzos G; Fischer H; Bäckman L
    Hum Brain Mapp; 2015 Apr; 36(4):1325-34. PubMed ID: 25486867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociable fronto-striatal effects of dopamine D2 receptor stimulation on cognitive versus motor flexibility.
    Stelzel C; Fiebach CJ; Cools R; Tafazoli S; D'Esposito M
    Cortex; 2013; 49(10):2799-811. PubMed ID: 23660437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance.
    Nymberg C; Banaschewski T; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Mann K; Martinot JL; Nees F; Paus T; Pausova Z; Rietschel M; Robbins TW; Smolka MN; Ströhle A; Schumann G; Klingberg T;
    Neuropsychopharmacology; 2014 Sep; 39(10):2357-65. PubMed ID: 24713612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRD2/ANKK1 TaqI A polymorphism affects corticostriatal activity in response to negative affective facial stimuli.
    Lee BT; Lee HY; Han C; Pae CU; Tae WS; Lee MS; Joe SH; Jung IK; Ham BJ
    Behav Brain Res; 2011 Sep; 223(1):36-41. PubMed ID: 21510979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
    Hirvonen MM; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
    Synapse; 2009 Oct; 63(10):907-12. PubMed ID: 19582781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.
    Bertolino A; Fazio L; Caforio G; Blasi G; Rampino A; Romano R; Di Giorgio A; Taurisano P; Papp A; Pinsonneault J; Wang D; Nardini M; Popolizio T; Sadee W
    Brain; 2009 Feb; 132(Pt 2):417-25. PubMed ID: 18829695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between DRD2/ANKK1 TaqIA Allele Status and Striatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder.
    Spitta G; Fliedner LE; Gleich T; Zindler T; Sebold M; Buchert R; Heinz A; Gallinat J; Friedel E
    J Integr Neurosci; 2022 Oct; 21(6):171. PubMed ID: 36424756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered brain activation in a reversal learning task unmasks adaptive changes in cognitive control in writer's cramp.
    Zeuner KE; Knutzen A; Granert O; Sablowsky S; Götz J; Wolff S; Jansen O; Dressler D; Schneider SA; Klein C; Deuschl G; van Eimeren T; Witt K
    Neuroimage Clin; 2016; 10():63-70. PubMed ID: 26702397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cortical mechanisms underlying individual differences in cognitive flexibility and stability.
    Armbruster DJ; Ueltzhöffer K; Basten U; Fiebach CJ
    J Cogn Neurosci; 2012 Dec; 24(12):2385-99. PubMed ID: 22905818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of DRD1 and DRD2 Receptors for Response Selection Under Varying Complexity Levels: Implications for Metacontrol Processes.
    Zink N; Bensmann W; Arning L; Colzato LS; Stock AK; Beste C
    Int J Neuropsychopharmacol; 2019 Dec; 22(12):747-753. PubMed ID: 31123756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine gene predicts the brain's response to dopaminergic drug.
    Cohen MX; Krohn-Grimberghe A; Elger CE; Weber B
    Eur J Neurosci; 2007 Dec; 26(12):3652-60. PubMed ID: 18088284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.
    Di Giorgio A; Smith RM; Fazio L; D'Ambrosio E; Gelao B; Tomasicchio A; Selvaggi P; Taurisano P; Quarto T; Masellis R; Rampino A; Caforio G; Popolizio T; Blasi G; Sadee W; Bertolino A
    PLoS One; 2014; 9(5):e95997. PubMed ID: 24819610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DRD2 and ANKK1 haplotype is associated with nicotine dependence.
    Voisey J; Swagell CD; Hughes IP; van Daal A; Noble EP; Lawford BR; Young RM; Morris CP
    Psychiatry Res; 2012 Apr; 196(2-3):285-9. PubMed ID: 22382052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.